This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Admiraal, P. J. Articles by Schalekamp, M. A. Search for Related Content PubMed PubMed Citation Articles by Admiraal, P. J. Articles by Schalekamp, M. A.

Hypertension, Vol 16, 555-563, Copyright © 1990 by American Heart Association

ARTICLES

Intrarenal de novo production of angiotensin I in subjects with renal artery stenosis

PJ Admiraal, FH Derkx, AH Danser, H Pieterman and MA Schalekamp
Department of Internal Medicine, University Hospital Dijkzigt, Rotterdam, The Netherlands.

To estimate the renal extraction and de novo production of angiotensin I and to assess the contribution of blood-borne renin to renal angiotensin I production, the aortic and renal venous plasma levels of renin and intact [125I]angiotensin I and endogenous angiotensin I during continuous systemic intravenous infusion of monoiodinated [125I]angiotensin I were measured in subjects with unilateral renal artery stenosis (n = 8) who were treated with captopril (50 mg b.i.d.). Results demonstrated that 80% of angiotensin I delivered by the renal artery was extracted both by the affected and the unaffected kidney and that on both sides a major part of angiotensin I in the renal vein was derived from intrarenal de novo production. Production of plasma angiotensin I was in excess over extraction (p less than 0.01) on the affected side, whereas extraction was in excess over production (p less than 0.01) on the contralateral side. The plasma level of de novo intrarenally produced angiotensin I in the renal vein was seven times higher on the affected side than the contralateral side. This difference was by far too big to be explained by a difference in the transit time of blood between the two kidneys, by an augmented production of angiotensin I in the circulating blood passing through the affected kidney due to the higher level of venous plasma renin activity in that kidney, or by the combination of both.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				H. Kobori, M. Nangaku, L. G. Navar, and A. Nishiyama The Intrarenal Renin-Angiotensin System: From Physiology to the Pathobiology of Hypertension and Kidney Disease Pharmacol. Rev., September 1, 2007; 59(3): 251 - 287. [Abstract] [Full Text] [PDF]

				R. K. Handa Angiotensin-(1-7) can interact with the rat proximal tubule AT4 receptor system Am J Physiol Renal Physiol, July 1, 1999; 277(1): F75 - F83. [Abstract] [Full Text] [PDF]

				M.-L. Lachurie, M. Azizi, T.-T. Guyene, F. Alhenc-Gelas, and J. Menard Angiotensin-Converting Enzyme Gene Polymorphism Has No Influence on the Circulating Renin-Angiotensin-Aldosterone System or Blood Pressure in Normotensive Subjects Circulation, June 15, 1995; 91(12): 2933 - 2942. [Abstract] [Full Text]